Wonik Co Ltd

Wonik Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.17, indicating limited leverage relative to its equity base. The company's liquidity position is assessed as medium, with a current ratio of 0.93, suggesting that its current liabilities slightly exceed its current assets. Free cash flow of 2.65 billion KRW supports operational flexibility, though cash and equivalents of 235.9 million KRW are modest relative to total assets of 382.2 billion KRW. Profitability metrics show a return on equity of 4.05% and a return on assets of 3.01%, both below the typical thresholds for high-margin healthcare equipment firms. The gross profit margin of 47.7% (71.9 billion KRW on 150.7 billion KRW revenue) is in line with industry norms, but operating margin of 5.8% (8.7 billion KRW) suggests pressure from operating expenses. Net income of 11.5 billion KRW reflects a 7.6% margin, which is acceptable for a diversified trade and distribution model. The company's revenue is distributed across three segments: Healthcare Trade, Electronic Components, and Others. The Healthcare Trade segment is the primary revenue driver, with a focus on medical equipment and consumables. The Electronic Components segment provides hybrid integrated circuits and RF filters, while the Others segment includes food service and real estate management. Revenue concentration data is not disclosed, but the diversified segmental exposure suggests moderate risk from any single market. Looking ahead, the company's revenue is projected to grow at a modest pace, with no significant directional change expected in the next fiscal year. Capital expenditure of -11.28 billion KRW indicates a reduction in investment, which may reflect a strategic shift or cost containment. The company's price-to-earnings ratio of 17.07 and price-to-book ratio of 0.69 suggest a relatively undervalued position compared to industry peers. Risk factors include a negative net cash position after subtracting total debt, which could limit financial flexibility. The company's dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. However, the absence of a clear growth strategy and reliance on trade and distribution rather than product innovation may constrain long-term value creation. Recent events include the latest financial filing, which reported a last actual EPS of 2,577.00 KRW. No significant earnings surprises or strategic announcements were disclosed in the most recent investor relations communications. The company's focus on import and supply operations suggests a stable but low-growth trajectory.